Short Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Declines By 10.2%

bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the target of a large decline in short interest in January. As of January 31st, there was short interest totalling 104,300 shares, a decline of 10.2% from the January 15th total of 116,100 shares. Based on an average trading volume of 4,900 shares, the days-to-cover ratio is presently 21.3 days.

bioMérieux Price Performance

Shares of BMXMF traded up $2.16 on Thursday, hitting $118.91. The company's stock had a trading volume of 21 shares, compared to its average volume of 1,624. The company has a quick ratio of 1.20, a current ratio of 2.21 and a debt-to-equity ratio of 0.10. bioMérieux has a fifty-two week low of $93.50 and a fifty-two week high of $123.44. The company has a 50 day moving average price of $112.45 and a 200 day moving average price of $111.62.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.